Ozempic®
$149.00
A once weekly treatment for type 2 diabetes that also lowers cardiovascular risk in eligible adults.
FDA-approved GLP-1 treatment
Reviewed by licensed US providers
Fast, discreet delivery and ongoing support
Ozempic®
0.25 mg
$149.00
Our customers say
Rated 4.7 Trustpilot
Trustpilot
Quick summary
Type of Medicine
Once weekly GLP-1 injection for type 2 diabetes and cardiovascular risk reduction
Generic
No
Active Ingredient
Semaglutide, in a once weekly prefilled diabetes pen
Effective Within
Blood sugar typically starts improving within the first two weeks, with the fuller effect on long term glucose control seen across eight to twelve weeks.
Works By
Prompts insulin release when glucose is high, slows stomach emptying and reduces appetite signals.
Side Effects
Nausea and looser stools are common as the dose rises, usually settling with time. In people also taking insulin or sulfonylureas, low blood sugar becomes a more important watch point.
Ozempic®, Wegovy® pen or pill?
Novo Nordisk
Wegovy® penFrom $199.00
Novo Nordisk
Wegovy® pillFrom $149.00
Novo Nordisk
Ozempic®From $149.00
Novo Nordisk
Wegovy® penFrom $199.00
Novo Nordisk
Wegovy® pillFrom $149.00
Novo Nordisk
Ozempic®From $149.00
How it’s taken
One injection once a week.
One tablet once a day
One injection once a week.
Average weight loss
Lose around 15–19% of body weight, depending on dose*
Lose around 14% of body weight*
Not licensed for weight management. But it can be prescribed off-label.
Best for
People who prefer a weekly routine
People who prefer no needles
People who prefer a weekly routine
How to take it
Inject under the skin using a pre-filled pen
Take on an empty stomach with water
Inject under the skin using a pre-filled pen
Payment options
Cash-pay or insurance may be available
Cash-pay only
Cash-pay or insurance may be available
Product details
Ozempic is a once weekly injection of semaglutide developed for adults living with type 2 diabetes. It improves blood sugar control by prompting the body to release insulin when glucose runs high and by slowing how quickly the stomach empties, smoothing out the peaks and dips across the day.
Beyond glucose, it earned a further approval for reducing the risk of serious cardiovascular events, such as heart attack and stroke, in adults who have type 2 diabetes alongside established heart disease. That dual benefit is a large part of why it has become so widely relied upon in diabetes care.
One point is worth stating plainly. Ozempic is approved for diabetes and heart risk, not for weight loss. The medicine licensed specifically for weight management is Wegovy, which contains the same molecule at doses studied for that purpose. A clinician will always prescribe according to the approved use.
- Steadies blood sugar through several complementary actions
- Also approved to lower cardiovascular risk in eligible adults
- Given once a week from a prefilled pen, on any chosen day
As with all GLP-1 medicines it carries a thyroid tumor boxed warning and is unsuitable for anyone with a history of medullary thyroid cancer or MEN 2. It is available only on prescription.
Semaglutide as the active ingredient, in a sterile solution for injection.
How it works
From question to doorstep, in days not weeks.
Your success is worth celebrating
Real people. Real progress. Real support.